Kancharla, Papireddy published the artcileLead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials, Recommanded Product: (4-(Bromomethyl)phenyl)(trifluoromethyl)sulfane, the publication is Journal of Medicinal Chemistry (2020), 63(11), 6179-6202, database is CAplus and MEDLINE.
The global impact of malaria remains staggering despite extensive efforts to eradicate the disease. With increasing drug resistance and the absence of a clin. available vaccine, there is an urgent need for novel, affordable, and safe drugs for prevention and treatment of malaria. Previously, we described a novel antimalarial acridone chemotype that is potent against both blood-stage and liver-stage malaria parasites. Here, we describe an optimization process that has produced a second-generation acridone series with significant improvements in efficacy, metabolic stability, pharmacokinetics, and safety profiles. These findings highlight the therapeutic potential of dual-stage targeting acridones as novel drug candidates for further preclin. development.
Journal of Medicinal Chemistry published new progress about 21101-63-3. 21101-63-3 belongs to bromides-buliding-blocks, auxiliary class Trifluoromethyl,Fluoride,Bromide,sulfides,Benzyl bromide,Benzene, name is (4-(Bromomethyl)phenyl)(trifluoromethyl)sulfane, and the molecular formula is C8H6BrF3S, Recommanded Product: (4-(Bromomethyl)phenyl)(trifluoromethyl)sulfane.
Referemce:
https://en.wikipedia.org/wiki/Bromide,
bromide – Wiktionary